We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
-15.37%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$2.72B
AUM Growth
-$201M
Cap. Flow
+$308M
Cap. Flow %
11.36%
Top 10 Hldgs %
17.25%
Holding
2,598
New
807
Increased
558
Reduced
485
Closed
731

Top Buys

Rank Stock Value
1
JOYY
JOYY Inc
JOYY
+$40.6M
2
VIPS icon
Vipshop
VIPS
+$37.9M
3
BABA icon
Alibaba
BABA
+$24.5M
4
MRVL icon
Marvell Technology
MRVL
+$19.5M
5
YUMC icon
Yum China
YUMC
+$17.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$56.7M
2
NTES icon
NetEase
NTES
+$49.3M
3
TSM icon
TSMC
TSM
+$32M
4
JD icon
JD.com
JD
+$31.2M
5
EDU icon
New Oriental
EDU
+$17.4M

Sector Composition

Rank Sector Weight
1 Technology 11.81%
2 Consumer Discretionary 9.34%
3 Healthcare 7.04%
4 Financials 6.93%
5 Industrials 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
1801
DELISTED
Clovis Oncology, Inc.
CLVS
$2K ﹤0.01%
1,267
-13,936
-92% -$20.6K
ABOS icon
1802
Acumen Pharmaceuticals
ABOS
$176M
$1K ﹤0.01%
292
-589
-67% -$2.21K
ABUS icon
1803
Arbutus Biopharma
ABUS
$915M
$1K ﹤0.01%
+423
New +$1.08K
AVAH icon
1804
Aveanna Healthcare
AVAH
$2.07B
$1K ﹤0.01%
+620
New +$1.8K
AVTX icon
1805
Avalo Therapeutics
AVTX
$983M
$1K ﹤0.01%
1
BRCC icon
1806
BRC Inc
BRCC
$250M
$1K ﹤0.01%
+117
New +$1.61K
CPSS icon
1807
Consumer Portfolio Services
CPSS
$206M
$1K ﹤0.01%
+50
New +$609
CTSO icon
1808
Cytosorbents Corp
CTSO
$22.6M
$1K ﹤0.01%
413
+154
+59% +$354
CUE icon
1809
Cue Biopharma
CUE
$114M
$1K ﹤0.01%
8
-72
-90% -$8.42K
DYN icon
1810
Dyne Therapeutics
DYN
$4.9B
$1K ﹤0.01%
132
-454
-77% -$3.13K
FBK icon
1811
FB Financial Corp
FBK
$3.04B
$1K ﹤0.01%
28
-1,588
-98% -$64K
FORR icon
1812
Forrester Research
FORR
$224M
$1K ﹤0.01%
+15
New +$777
GHRS icon
1813
GH Research
GHRS
$2.08B
$1K ﹤0.01%
80
INVA icon
1814
Innoviva
INVA
$1.48B
$1K ﹤0.01%
95
-3,847
-98% -$63K
IREN icon
1815
Iris Energy
IREN
$14.7B
$1K ﹤0.01%
168
KNSA icon
1816
Kiniksa Pharmaceuticals
KNSA
$5.93B
$1K ﹤0.01%
60
+45
+300% +$420
LVLU icon
1817
Lulu's Fashion Lounge
LVLU
$52.3M
$1K ﹤0.01%
6
-87
-94% -$15.4K
NVEC icon
1818
NVE Corp
NVEC
$609M
$1K ﹤0.01%
+12
New +$583
OMER icon
1819
Omeros
OMER
$959M
$1K ﹤0.01%
+329
New +$1.11K
PFBC icon
1820
Preferred Bank
PFBC
$1.25B
$1K ﹤0.01%
+15
New +$1.03K
PRPL icon
1821
Purple Innovation
PRPL
$41.7M
$1K ﹤0.01%
9
-346
-97% -$40.2K
RCEL icon
1822
Avita Medical
RCEL
$240M
$1K ﹤0.01%
+145
New +$896
RPAY icon
1823
Repay Holdings
RPAY
$327M
$1K ﹤0.01%
82
-6,532
-99% -$85K
SHAK icon
1824
Shake Shack
SHAK
$2.87B
$1K ﹤0.01%
19
-2,498
-99% -$127K
SHBI icon
1825
Shore Bancshares
SHBI
$796M
$1K ﹤0.01%
+41
New +$810

Similar funds

Point72 Hong Kong's Q2 2022 Portfolio in Review

As of Q2 2022, Point72 Hong Kong held 2,598 positions worth $2.72B, down 6.9% from $2.92B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Point72 Hong Kong deployed $308M of net new capital in Q2 2022, opening 807 new positions and adding to 558 existing holdings. Its largest new stake was JOYY Inc: 1,103,562 shares worth $33M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 7.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was JD.com, an estimated $31.2M trimmed.

  • Point72 Hong Kong's largest Q2 2022 buy was JOYY Inc: 1,103,562 shares worth $33M.
  • Point72 Hong Kong added most to Yum China in Q2 2022, an estimated $17.6M increase.
  • Point72 Hong Kong's biggest Q2 2022 reduction was JD.com, cutting an estimated $31.2M.
  • Point72 Hong Kong fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $56.7M.
  • Point72 Hong Kong's ten largest holdings make up 17% of its $2.72B portfolio in Q2 2022.
  • Point72 Hong Kong opened 807 new positions and closed 731 in Q2 2022.
  • Point72 Hong Kong's portfolio value fell 6.9% quarter-over-quarter to $2.72B.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.